Reference is made to the offer document dated
All of the Company's option holders, representing all of the outstanding 1,200,850 options in the Company (the "Company Options"), have irrevocably committed to exercise the Company Options to subscribe for Shares in the Company and to sell such Shares to the Offeror on the same terms and conditions as the Offer.
Based on the authorization granted at the annual general meeting of
The share capital increase has been registered and the Company's new share capital is
***
For more information, please contact:
E-mail: robert.schrama@nattopharma.com
This information is subject to the disclosure requirements pursuant to section 5-12 of the
https://news.cision.com/nattopharma-asa/r/new-share-capital-registered,c3315787
https://mb.cision.com/Main/2037/3315787/1393988.pdf
(c) 2021 Cision. All rights reserved., source